|
Terminator Seed Lands
Monsanto's Shapiro with Egg, Pie on Face
By John
K. Wilson Bankrate.com
| |
| Monsanto Co. |
St. Louis, MO
(314) 694-2883 |
| Monsanto.com
|
| NYSE: MTC |
| Industry/Sector: Genetically engineered
foods/ Biotechnology |
| Annual Revenue: $9.2 billion (Q
ended Sept. '99) |
| Annual Net Income: Loss of $78 million
(Q ended Sept. '99) |
| Market Cap: $24.4 billion |
| Employees: 30,000 |
| Players: Robert Shapiro, Chairman
and CEO;Hendrik Verfaillie, President and COO; Richard
De Schutter, Chief Administrative Officer; Gary Crittenden,
Senior VP and CFO |
Monsanto CEO Robert Shapiro has seen the future, and
it is made of pie.
He saw it a little too closely in October 1998 when
Agent Custard and Agent Lemon Meringue (not their real names) of
the pie-throwing Biotic Baking Brigade tossed a vegan tofu creme
pie in Shapiro's face (the sweet potato pie missed).
If Shapiro hadn't realized that biotechnology can
act as a lightning rod for controversy, the pie offered a tasty
reminder.
The troubles for Monsanto and Shapiro have continued
this year. Even worse than the pie was the baby food spit in his
face, if only symbolically.
In August, Gerber announced that it would no longer
use genetically engineered products in its baby foods, followed
soon after by Heinz.
And before the baby food, it was the butterflies:
a Cornell University study made headlines in March because it found
that Monarch caterpillars frequently died if they ate milkweed leaves
sprinkled with genetically engineered corn pollen.
Monsanto has found itself in a defensive mode, offering
up spin control. In October, Monsanto -- which made $49 million
on $1.9 billion in sales during its third quarter -- announced that
it would abandon its controversial "terminator technology," a form
of genetic engineering that makes second-generation seeds sterile.
And Shapiro himself has admitted that genetic engineering is a radical
step: "Almost everything we grow, everything we eat is the root
result of human intervention, breeding, and so on. But this is unnatural
in a different sort of way from the kinds of breeding programs that
have characterized humanity for thousands of years."
The moral, environmental, and scientific dimensions
of this debate do not interest Wall Street, but the fact that there
is a debate at all must trouble Monsanto shareholders who imagined
ballooning profits as the company that brought us PCBs now tries
to get rich feeding the world.
The world has not proven grateful, however. Activists
in India have burned genetic engineering test sites, and Europe
has also been skeptical of "the Second Green Revolution" as U.S.
Department of Agriculture Secretary Dan Glickman enthusiastically
calls it. A $1.5 million campaign by Monsanto to convince European
consumers of the value and safety of genetically engineered foods
failed miserably, and resistance is strong from supermarkets that
have banned genetically engineered products from their shelves,
activists who protest the biotech industry, and vandals who destroy
test fields. Analysts from Deutsche Bank have issued reports on
Genetically Modified Organisms (GMOs) bluntly titled "GMOs are dead"
and "Ag Biotech: Thanks, But No Thanks," predicting that "GMOs,
once perceived as a bull case for this sector, will now be perceived
as a pariah."
Of course, Americans don't care what Europeans think,
but American farmers care about what they buy. It's estimated that
in American fields this year, 57 percent of the soybeans and 38
percent of the corn planted used genetically engineered seeds to
increase pest or pesticide resistance. But farmers were shocked
when grain buyers such as ADM announced shortly before harvest that
they wanted the genetically engineered crops kept separate from
the non-genetically engineered plants. The move came after U.S.
corn sales to Europe dropped from 70 million bushels in 1997 to
just 3 million in 1998 due to European restrictions. U.S. agriculture
experts expect that in next year's crops, genetically engineered
planting will drop between 20 percent and 60 percent.
This is a heavy blow to Monsanto, but the company
may end up stronger in the end. If the protests scare away competition
and genetically engineered crops weather this storm, Monsanto will
be the reigning force in biotechnology.
The company has taken matters into its own hands,
having organized a counter-protest against the environmental protests.
The New York Times on Dec. 8 reported that Monsanto partially
funded a demonstration by 100 members of the Mount Lebanon Baptist
Church of Washington, DC against anti-Monsanto protesters dressed
as seed-damaged monarch butterflies. According to the article, some
of the Mount Lebanon protesters received remuneration -- 25 bones
each! -- from the company. Larry DeNeal, one of the organizers of
the Mount Lebanon group, declined comment for the church.
The moral, environmental, and scientific dimensions
of this debate do not interest Wall Street, but the fact that there
is a debate at all must trouble Monsanto shareholders who imagined
ballooning profits as the company tries to get rich feeding the world.
Protests and religious groups aside, the future of
Monsanto and genetic engineering rests squarely on the American
consumer. The World Trade Organization, with its unrelenting devotion
to free trade, may eventually respond to U.S. demands and force
Europe to accept genetically engineered foods without discrimination
or labeling. But there's a growing movement in America to require
labeling on these products, which, if successful, would make it
impossible to push the issue in the WTO.
That's one reason why Monsanto spent $2 million on
Washington lobbyists in the first half of 1999 and recently hired
Griffin, Johnson, Dover & Stewart Inc., a firm that features
Patrick Griffin, Clinton's former chief congressional lobbyist,
and David Johnson, former director of the Democratic Senatorial
Campaign Committee.
Monsanto also knows how to play hardball: a Florida
Fox news station killed a report on a genetically engineered growth
hormone used on cows to produce more milk after Monsanto threatened
"dire consequences."
Journalists Jane Akre and Steve Wilson, who were fired
by Fox for refusing to change their report, have filed a lawsuit
over the issue. Monsanto has also fought efforts to allow labeling
of rBGH-free dairy products.
But the tide may be turning. U.S. environmental groups
have amassed hundreds of thousands of signatures on petitions demanding
labeling of genetically engineered foods and Rep. Dennis Kucinich
(D-Ohio) has introduced a bill to require labeling, The Genetically
Engineered Food Right to Know Act, with 20 co-sponsors (including
four Republicans). Forty-seven members of Congress have also asked
the FDA to require labeling of genetically engineered foods.
Last month, the Food and Drug Administration held
its first public hearing on genetically engineering food in Chicago.
The response to the hastily arranged event was so overwhelming that
most of the audience had to watch via satellite from a hotel a mile
away. Additional hearings will be held in Washington D.C. and Oakland,
Calif.
The Chicago public hearing was deeply polarized, with
consumer advocates and environmentalists demanding more regulation
and labeling of GE foods, while industry officials strongly supported
the current regimen of weak FDA oversight. The media proved to be
more interested in a protest outside organized by Sustain USA and
Greenpeace, which featured a protestor dressed as genetically engineered
corn killing Monarch butterfly-costumed children and a mad scientist
injecting a cow with recombinant Bovine Growth Hormone.
With rumor mergers swirling around Monsanto, biotechnology
could represent the next wave of fast-rising tech firms, or an industry
that faces a severe drought until consumers are convinced of the
safety of genetically engineered foods.
For the moment, Robert Shapiro is keeping his eye
out for flying pies.
-- Posted: Dec. 9, 1999
|